Stoke Therapeutics (NASDAQ:STOK) General Counsel Sells $43,637.15 in Stock

Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) General Counsel Jonathan Allan sold 1,457 shares of the firm’s stock in a transaction that occurred on Tuesday, June 16th. The stock was sold at an average price of $29.95, for a total transaction of $43,637.15. Following the transaction, the general counsel directly owned 18,086 shares in […]